BG37836A3 - Method for preparing 4- quinoline derivatives - Google Patents

Method for preparing 4- quinoline derivatives

Info

Publication number
BG37836A3
BG37836A3 BG8047135A BG4713580A BG37836A3 BG 37836 A3 BG37836 A3 BG 37836A3 BG 8047135 A BG8047135 A BG 8047135A BG 4713580 A BG4713580 A BG 4713580A BG 37836 A3 BG37836 A3 BG 37836A3
Authority
BG
Bulgaria
Prior art keywords
preparing
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
BG8047135A
Other languages
English (en)
Inventor
Davies
Fraser
Nichol
Parkinson
Yates
Sim
Original Assignee
Boots Co Plc (The),Gb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc (The),Gb filed Critical Boots Co Plc (The),Gb
Publication of BG37836A3 publication Critical patent/BG37836A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG8047135A 1979-03-27 1980-03-26 Method for preparing 4- quinoline derivatives BG37836A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27
GB7939505 1979-11-15

Publications (1)

Publication Number Publication Date
BG37836A3 true BG37836A3 (en) 1985-08-15

Family

ID=26271029

Family Applications (2)

Application Number Title Priority Date Filing Date
BG8466170A BG37993A3 (en) 1979-03-27 1980-03-26 Method for preparing 4- quinolonic derivatives
BG8047135A BG37836A3 (en) 1979-03-27 1980-03-26 Method for preparing 4- quinoline derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG8466170A BG37993A3 (en) 1979-03-27 1980-03-26 Method for preparing 4- quinolonic derivatives

Country Status (34)

Country Link
US (1) US4302460A (fr)
KR (1) KR840001612B1 (fr)
AT (1) AT379390B (fr)
AU (1) AU536616B2 (fr)
BG (2) BG37993A3 (fr)
CA (1) CA1151652A (fr)
CH (1) CH644366A5 (fr)
CS (1) CS221906B2 (fr)
DD (1) DD149608A5 (fr)
DE (2) DE3051205C2 (fr)
DK (1) DK151252C (fr)
EG (1) EG16606A (fr)
FI (1) FI77026C (fr)
FR (2) FR2452484A1 (fr)
GR (1) GR68007B (fr)
HK (1) HK94986A (fr)
HU (1) HU179845B (fr)
IE (1) IE49562B1 (fr)
IL (1) IL59710A (fr)
IT (1) IT1188916B (fr)
KE (1) KE3649D (fr)
LU (1) LU82295A1 (fr)
MX (1) MX6816E (fr)
MY (1) MY8600668A (fr)
NL (1) NL191306C (fr)
NO (1) NO156787C (fr)
NZ (1) NZ193167A (fr)
PH (1) PH16758A (fr)
PL (1) PL124037B1 (fr)
PT (1) PT71006A (fr)
RO (1) RO79397A (fr)
SE (1) SE455422B (fr)
SG (1) SG60886G (fr)
YU (1) YU42332B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4552884A (en) * 1984-01-13 1985-11-12 The Boots Company Plc Method of treating heart disease
EP0172004B1 (fr) * 1984-08-15 1990-03-21 The Boots Company PLC Quinolinones, procédé pour leur préparation et compositions pharmaceutiques les contenant
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
FR2680511B1 (fr) * 1991-08-20 1995-05-19 Roussel Uclaf Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant.
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
FR2684671B1 (fr) * 1991-11-20 1995-05-19 Roussel Uclaf Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments.
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
WO2000007595A1 (fr) * 1998-08-03 2000-02-17 Basf Corporation Utilisation de pyridinones pour traiter les dysfonctionnements sexuels
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1066919A (en) 1964-04-03 1967-04-26 Hoffmann La Roche Novel benzyl amine derivatives
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
US3798219A (en) * 1971-10-18 1974-03-19 Warner Lambert Co 3-(methylsulfinyl)cinnolinones and their derivatives
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
CH607848A5 (fr) * 1974-06-04 1978-11-30 Bayer Ag
GB1488411A (en) * 1975-01-16 1977-10-12 Wyeth John & Brother Ltd 3,4-dihydro-4-arylquinolin-4-ol derivatives
US4127574A (en) * 1976-03-01 1978-11-28 Sandoz, Inc. 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
US4124587A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
DE2616991A1 (de) 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616995A1 (de) 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639257A1 (de) 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639498A1 (de) 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2641746C2 (de) 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2658183A1 (de) 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5424882A (en) * 1977-07-22 1979-02-24 Yamanouchi Pharmaceut Co Ltd Novel heterocyclic compounds and their preparation
DE2747513A1 (de) 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen

Also Published As

Publication number Publication date
FR2468367B1 (fr) 1983-09-30
DD149608A5 (de) 1981-07-22
KE3649D (en) 1986-08-01
ATA161880A (de) 1985-05-15
NL191306B (nl) 1994-12-16
PH16758A (en) 1984-02-15
AU536616B2 (en) 1984-05-17
YU42332B (en) 1988-08-31
NL8001771A (nl) 1980-09-30
IE49562B1 (en) 1985-10-30
GR68007B (fr) 1981-10-26
LU82295A1 (fr) 1981-04-17
SE8002345L (sv) 1980-11-14
CH644366A5 (fr) 1984-07-31
NO156787B (no) 1987-08-17
YU84980A (en) 1983-09-30
US4302460A (en) 1981-11-24
RO79397A (fr) 1982-06-25
NO800881L (no) 1980-09-29
NO156787C (no) 1987-11-25
IE800567L (en) 1980-09-27
NZ193167A (en) 1984-08-24
IT8048262A0 (it) 1980-03-26
FI77026B (fi) 1988-09-30
HK94986A (en) 1986-12-12
AT379390B (de) 1985-12-27
AU5670280A (en) 1980-10-02
MX6816E (es) 1986-08-05
HU179845B (en) 1982-12-28
PL124037B1 (en) 1982-12-31
KR840001612B1 (ko) 1984-10-11
DK130180A (da) 1980-09-28
DK151252C (da) 1988-05-16
IT8048262A1 (it) 1981-09-26
DE3051205C2 (de) 1991-01-24
FR2452484A1 (fr) 1980-10-24
IT1188916B (it) 1988-01-28
PL223050A1 (fr) 1981-01-30
CS221906B2 (en) 1983-04-29
NL191306C (nl) 1995-05-16
CA1151652A (fr) 1983-08-09
IL59710A (en) 1984-01-31
MY8600668A (en) 1986-12-31
SG60886G (en) 1987-03-27
SE455422B (sv) 1988-07-11
FI77026C (fi) 1989-01-10
DE3011994C2 (fr) 1991-06-27
KR830001898A (ko) 1983-05-19
EG16606A (en) 1989-01-30
DK151252B (da) 1987-11-16
PT71006A (en) 1980-04-01
FI800923A (fi) 1980-09-28
FR2468367A1 (fr) 1981-05-08
FR2452484B1 (fr) 1983-08-12
BG37993A3 (en) 1985-09-16
DE3011994A1 (de) 1980-10-16

Similar Documents

Publication Publication Date Title
BG37836A3 (en) Method for preparing 4- quinoline derivatives
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
YU6280A (en) Process for preparing new pleuromutiline derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG34908A3 (en) Method for preparing d- 6- n- propylergolines
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG35042A3 (en) Method for preparing benzodiazepinic compounds
BG35746A3 (en) Method for preparing 1- cyclohexenylmethylpyrolidines
BG40803A3 (en) Method for preparing arylcyclobutylalkylaminic derivatives
BG36934A3 (en) Method for preparing sulphuric- containing isoquinolinic derivatives
HU182115B (en) Process for preparing 6-subsituted pyranone derivatives
PT71328A (en) Process for preparing new hydroxyamino-eburnane derivatives
BG36344A3 (en) Method for preparing 4- quinoline derivatives
BG37994A3 (en) Method for preparing tetrahydroquinolinic derivatives
PT71812B (en) Process for preparing pyridazopyridazine derivatives
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG40315A3 (en) Method for preparing auronic derivatives
BG35035A3 (en) Method for preparing nitroalkanolic derivatives
PT71807B (en) Process for preparing 15-sulfonamidoprostaglandin derivatives
HU178523B (en) Process for preparing new pyrazolo-quinazoline derivatives
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG35037A3 (en) Method for preparing phenylaminic derivatives
BG36633A3 (en) Method for preparing 3- hydroxycephalosporines
BG36345A3 (en) Method for preparing cyclopentenic derivatives